A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Nov 2026 → Nov 2028
See other at-risk trials from Memorial Sloan Kettering Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Nov 2026 to Nov 2028 Show 4 more changesShow less
    • Enrollment reopened
    • Enrollment increased: 51 → 80 participants
    • Eligibility criteria expanded, about 18 words
    • Site details revised at 4 of 4 sites
  2. Primary and study completion dates: Nov 2025 to Nov 2026v14
  3. Re-verified, no change to tracked fieldsv13
  4. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 80 to confirmed 51
    • Site details revised at 4 of 4 sites
    v12
  5. Primary and study completion dates: Nov 2023 to Nov 2025v11
Show 9 earlier versionsHide 9 earlier versions
  1. Study sites revised (4)v10
  2. Re-verified, no change to tracked fieldsv9
  3. Primary and study completion dates: Nov 2022 to Nov 2023v8
  4. Primary and study completion dates: Nov 2020 to Nov 2022v7
  5. Re-verified, no change to tracked fieldsv6
  6. Primary and study completion dates: Nov 2019 to Nov 2020v5
  7. Re-verified, no change to tracked fieldsv4
  8. Primary and study completion dates: Nov 2018 to Nov 2019
    • Interventions: blood draws (Other), colectomy or hepatectomy (Procedure) to Fibroscan test (Diagnostic Test), blood draws (Other), colectomy or hepatectomy (Procedure)
    v3
  9. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to explore novel ways of diagnosing colon cancer and predicting its propensity to spread to other organs such as the liver.
Trial Details
NCT Number NCT03432806
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Weill Medical College of Cornell University
Conditions
(from sponsor)		 Colon Cancer, Liver Tumors
Related terms Carcinoma, Hepatocellular, Colonic Neoplasms
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov